Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 30.9 Cr.
- Current Price ₹ 12.5
- High / Low ₹ 23.0 / 6.65
- Stock P/E 12.4
- Book Value ₹ 44.6
- Dividend Yield 0.00 %
- ROCE 3.28 %
- ROE 2.30 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.28 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.5%
- Company has a low return on equity of 1.72% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.06 | 81.90 | |
| 30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 71.92 | 76.81 | |
| Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.14 | 5.09 |
| OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 4.18% | 6.21% |
| 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.07 | 0.37 |
| Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.46 |
| Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.63 | 3.27 |
| Tax % | 0.39% | 25.00% | 40.00% | 31.82% | 33.03% | 28.83% | 23.85% |
| 10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | 2.49 | |
| EPS in Rs | 6.42 | 0.25 | 0.20 | 0.18 | 0.73 | 0.50 | 1.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 100% |
| TTM: | 115% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -17% |
| 3 Years: | -28% |
| 1 Year: | -42% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 60.52 | 60.91 | 61.23 | 64.52 | 76.53 | 82.97 | 85.51 |
| 0.87 | 1.03 | 1.25 | 1.61 | 1.90 | 1.15 | 3.96 | |
| 15.89 | 14.61 | 12.44 | 13.62 | 9.24 | 17.38 | 34.69 | |
| Total Liabilities | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 | 148.91 |
| 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 15.02 | |
| CWIP | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 37.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 33.84 | 72.32 | 72.10 | 79.94 | 92.36 | 110.55 | 133.89 | |
| Total Assets | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 | 148.91 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 2.68 | 0.22 | -0.57 | -6.76 | -12.55 | -6.43 | -3.62 | |
| -1.94 | -0.07 | -0.05 | 0.27 | -0.30 | -0.14 | -2.25 | |
| -1.77 | -0.37 | 0.07 | 5.26 | 14.04 | 7.52 | 3.96 | |
| Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 | 0.95 | -1.91 |
| Free Cash Flow | 0.87 | 0.06 | -0.63 | -6.51 | -12.86 | -6.57 | -5.86 |
| CFO/OP | 23% | 18% | -6% | -334% | -334% | -204% | -71% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 60.98 | 75.72 |
| Inventory Days | 0.00 | 890.81 | 1,182.75 | 683.64 | 445.05 | 327.35 | 340.22 |
| Days Payable | 112.09 | 147.78 | 123.28 | 41.68 | 69.00 | 143.23 | |
| Cash Conversion Cycle | 177.66 | 913.46 | 1,176.04 | 657.58 | 463.81 | 319.32 | 272.71 |
| Working Capital Days | 421.77 | 545.99 | 603.01 | 507.69 | 477.13 | 423.01 | 418.97 |
| ROCE % | 0.81% | 5.62% | 0.68% | 2.53% | 1.65% | 3.28% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Employee Strength (Total) Number ・Standalone data |
|
|||||||
| Number of Marketing Agents Count ・Standalone data |
||||||||
| Number of SKUs Count ・Standalone data |
||||||||
| Recipe Portfolio Count Count ・Standalone data |
||||||||
| Monthly Installed Capacity - Hard Gel Food Pills Units ・Standalone data |
||||||||
| Monthly Installed Capacity - Soft Gel Food Pills Units ・Standalone data |
||||||||
| Monthly Installed Capacity - Tablet Food Pills Units ・Standalone data |
||||||||
| Number of Distributors Count ・Standalone data |
||||||||
| Unit Distribution (Iron-Enriched Fruit Bars) Units ・Standalone data |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Intimation of Newspaper Publication of Financial Results for the quarter and year ended March 31, 2026.
-
Audited Standalone And Consolidated Results For FY 2025-26
30 May - Board approved FY26 standalone and consolidated audited results on 30 May 2026; auditors issued unmodified opinion.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30 May - Deccan Healthcare issued a press release on annual results and corporate update on 30 May 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting- To Considered And Approved The Standalone And Consolidated Audited Financial Results Of The Company For The Year Ended On March 31, 2026 Along With Auditor''s Report With Unmodified Opinion.
30 May - Board approved FY26 standalone and consolidated audited results on 30 May 2026; auditors gave unmodified opinion.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - FY26 secretarial compliance report notes delayed compliance, board composition issues, and fines totaling about Rs 10.3 lakh.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com